Skip to contents

Get information of interest (e.g., endpoint) from long data frame of protocol- or result-related trial information as returned by dfTrials2Long. Parameters `valuename`, `wherename` and `wherevalue` are matched using Perl regular expressions and ignoring case.

Usage

dfName2Value(df, valuename = "", wherename = "", wherevalue = "")

Arguments

df

A data frame (or tibble) with four columns (`_id`, `identifier`, `name`, `value`) as returned by dfTrials2Long

valuename

A character string for the name of the field that holds the value of the variable of interest (e.g., a summary measure such as "endPoints.*tendencyValue.value")

wherename

(optional) A character string to identify the variable of interest among those that repeatedly occur in a trial record (e.g., "endPoints.endPoint.title")

wherevalue

(optional) A character string with the value of the variable identified by `wherename` (e.g., "response")

Value

A data frame (or tibble, if dplyr is loaded) that includes the values of interest, with columns `_id`, `identifier`, `name`, `value` (and `where`, with the contents of `wherevalue` found at `wherename`). Contents of `value` are strings unless all its elements are numbers. The `identifier` is generated by function

dfTrials2Long to identify matching elements, e.g. endpoint descriptions and measurements.

Examples


dbc <- nodbi::src_sqlite(
   dbname = system.file("extdata", "demo.sqlite", package = "ctrdata"),
   collection = "my_trials")

dfwide <- dbGetFieldsIntoDf(
 fields = c(
  ## ctgov - typical results fields
  # "clinical_results.baseline.analyzed_list.analyzed.count_list.count",
  # "clinical_results.baseline.group_list.group",
  # "clinical_results.baseline.analyzed_list.analyzed.units",
  "clinical_results.outcome_list.outcome",
  "study_design_info.allocation",
  ## euctr - typical results fields
  # "trialInformation.fullTitle",
  # "baselineCharacteristics.baselineReportingGroups.baselineReportingGroup",
  # "trialChanges.hasGlobalInterruptions",
  # "subjectAnalysisSets",
  # "adverseEvents.seriousAdverseEvents.seriousAdverseEvent",
  "endPoints.endPoint",
  "subjectDisposition.recruitmentDetails"
  ), con = dbc)
#> clinical_results.outcome_list.outcome... 
#>     
#> . 
#> . 
#> 
#> study_design_info.allocation... 
#>     
#> . 
#> 
#> endPoints.endPoint... 
#>     
#> . 
#> 
#> subjectDisposition.recruitmentDetails... 
#>     
#> . 

dflong <- dfTrials2Long(df = dfwide)
#> clinical_results.outcome_list.outcome                                                                                                                                                                   

#> study_design_info.allocation                                                                                                                                                                            

#> endPoints.endPoint                                                                                                                                                                                      

#> subjectDisposition.recruitmentDetails                                                                                                                                                                   

#>                                                                                                                                                                                                         

#> . 
#> . 
#> . 
#> . 
#> . 
#> . 
#> . 
#> . 
#> 
#> Total 24916 rows, 91 unique names of variables

## get values for the endpoint 'response'
dfName2Value(
  df = dflong,
  valuename = paste0(
    "clinical_results.*measurement.value|",
    "clinical_results.*outcome.measure.units|",
    "endPoints.endPoint.*tendencyValue.value|",
    "endPoints.endPoint.unit"
  ),
  wherename = paste0(
    "clinical_results.*outcome.measure.title|",
    "endPoints.endPoint.title"),
  wherevalue = "response")
#> Returning values for 17 out of 56 trials
#>                   _id identifier
#> 1   2012-003632-23-AT          1
#> 2   2012-003632-23-AT          1
#> 3   2012-003632-23-AT          2
#> 4   2012-003632-23-AT          6
#> 5   2012-003632-23-AT        6.1
#> 6   2012-003632-23-AT        6.2
#> 7   2012-003632-23-AT        6.3
#> 8   2012-003632-23-AT        6.4
#> 9   2012-003632-23-AT        6.5
#> 10  2012-003632-23-AT          8
#> 11  2012-003632-23-AT          8
#> 12  2012-003632-23-CZ          1
#> 13  2012-003632-23-CZ          1
#> 14  2012-003632-23-CZ          2
#> 15  2012-003632-23-CZ          6
#> 16  2012-003632-23-CZ        6.1
#> 17  2012-003632-23-CZ        6.2
#> 18  2012-003632-23-CZ        6.3
#> 19  2012-003632-23-CZ        6.4
#> 20  2012-003632-23-CZ        6.5
#> 21  2012-003632-23-CZ          8
#> 22  2012-003632-23-CZ          8
#> 23  2012-003632-23-DE          1
#> 24  2012-003632-23-DE          1
#> 25  2012-003632-23-DE          2
#> 26  2012-003632-23-DE          6
#> 27  2012-003632-23-DE        6.1
#> 28  2012-003632-23-DE        6.2
#> 29  2012-003632-23-DE        6.3
#> 30  2012-003632-23-DE        6.4
#> 31  2012-003632-23-DE        6.5
#> 32  2012-003632-23-DE          8
#> 33  2012-003632-23-DE          8
#> 34  2012-003632-23-ES          1
#> 35  2012-003632-23-ES          1
#> 36  2012-003632-23-ES          2
#> 37  2012-003632-23-ES          6
#> 38  2012-003632-23-ES        6.1
#> 39  2012-003632-23-ES        6.2
#> 40  2012-003632-23-ES        6.3
#> 41  2012-003632-23-ES        6.4
#> 42  2012-003632-23-ES        6.5
#> 43  2012-003632-23-ES          8
#> 44  2012-003632-23-ES          8
#> 45  2012-003632-23-GB          1
#> 46  2012-003632-23-GB          1
#> 47  2012-003632-23-GB          2
#> 48  2012-003632-23-GB          6
#> 49  2012-003632-23-GB        6.1
#> 50  2012-003632-23-GB        6.2
#> 51  2012-003632-23-GB        6.3
#> 52  2012-003632-23-GB        6.4
#> 53  2012-003632-23-GB        6.5
#> 54  2012-003632-23-GB          8
#> 55  2012-003632-23-GB          8
#> 56  2012-003632-23-IT          1
#> 57  2012-003632-23-IT          1
#> 58  2012-003632-23-IT          2
#> 59  2012-003632-23-IT          6
#> 60  2012-003632-23-IT        6.1
#> 61  2012-003632-23-IT        6.2
#> 62  2012-003632-23-IT        6.3
#> 63  2012-003632-23-IT        6.4
#> 64  2012-003632-23-IT        6.5
#> 65  2012-003632-23-IT          8
#> 66  2012-003632-23-IT          8
#> 67  2012-003632-23-SE          1
#> 68  2012-003632-23-SE          1
#> 69  2012-003632-23-SE          2
#> 70  2012-003632-23-SE          6
#> 71  2012-003632-23-SE        6.1
#> 72  2012-003632-23-SE        6.2
#> 73  2012-003632-23-SE        6.3
#> 74  2012-003632-23-SE        6.4
#> 75  2012-003632-23-SE        6.5
#> 76  2012-003632-23-SE          8
#> 77  2012-003632-23-SE          8
#> 78  2013-005512-10-DE          4
#> 79  2013-005512-10-DE        4.1
#> 80  2013-005512-10-DE        4.2
#> 81  2013-005512-10-DE        4.3
#> 82  2013-005512-10-DE        4.4
#> 83  2013-005512-10-DE        4.5
#> 84  2013-005512-10-DE        4.6
#> 85  2013-005512-10-DE        4.7
#> 86  2013-005512-10-DE        4.8
#> 87  2013-005512-10-DE        4.9
#> 88  2013-005512-10-DE       4.10
#> 89  2013-005512-10-DE       4.11
#> 90  2013-005512-10-DE       4.12
#> 91  2013-005512-10-DE         10
#> 92  2013-005512-10-DK          4
#> 93  2013-005512-10-DK        4.1
#> 94  2013-005512-10-DK        4.2
#> 95  2013-005512-10-DK        4.3
#> 96  2013-005512-10-DK        4.4
#> 97  2013-005512-10-DK        4.5
#> 98  2013-005512-10-DK        4.6
#> 99  2013-005512-10-DK        4.7
#> 100 2013-005512-10-DK        4.8
#> 101 2013-005512-10-DK        4.9
#> 102 2013-005512-10-DK       4.10
#> 103 2013-005512-10-DK       4.11
#> 104 2013-005512-10-DK       4.12
#> 105 2013-005512-10-DK         10
#> 106 2013-005512-10-ES          4
#> 107 2013-005512-10-ES        4.1
#> 108 2013-005512-10-ES        4.2
#> 109 2013-005512-10-ES        4.3
#> 110 2013-005512-10-ES        4.4
#> 111 2013-005512-10-ES        4.5
#> 112 2013-005512-10-ES        4.6
#> 113 2013-005512-10-ES        4.7
#> 114 2013-005512-10-ES        4.8
#> 115 2013-005512-10-ES        4.9
#> 116 2013-005512-10-ES       4.10
#> 117 2013-005512-10-ES       4.11
#> 118 2013-005512-10-ES       4.12
#> 119 2013-005512-10-ES         10
#> 120 2013-005512-10-FR          4
#> 121 2013-005512-10-FR        4.1
#> 122 2013-005512-10-FR        4.2
#> 123 2013-005512-10-FR        4.3
#> 124 2013-005512-10-FR        4.4
#> 125 2013-005512-10-FR        4.5
#> 126 2013-005512-10-FR        4.6
#> 127 2013-005512-10-FR        4.7
#> 128 2013-005512-10-FR        4.8
#> 129 2013-005512-10-FR        4.9
#> 130 2013-005512-10-FR       4.10
#> 131 2013-005512-10-FR       4.11
#> 132 2013-005512-10-FR       4.12
#> 133 2013-005512-10-FR         10
#> 134 2013-005512-10-GB          4
#> 135 2013-005512-10-GB        4.1
#> 136 2013-005512-10-GB        4.2
#> 137 2013-005512-10-GB        4.3
#> 138 2013-005512-10-GB        4.4
#> 139 2013-005512-10-GB        4.5
#> 140 2013-005512-10-GB        4.6
#> 141 2013-005512-10-GB        4.7
#> 142 2013-005512-10-GB        4.8
#> 143 2013-005512-10-GB        4.9
#> 144 2013-005512-10-GB       4.10
#> 145 2013-005512-10-GB       4.11
#> 146 2013-005512-10-GB       4.12
#> 147 2013-005512-10-GB         10
#> 148 2013-005512-10-IE          4
#> 149 2013-005512-10-IE        4.1
#> 150 2013-005512-10-IE        4.2
#> 151 2013-005512-10-IE        4.3
#> 152 2013-005512-10-IE        4.4
#> 153 2013-005512-10-IE        4.5
#> 154 2013-005512-10-IE        4.6
#> 155 2013-005512-10-IE        4.7
#> 156 2013-005512-10-IE        4.8
#> 157 2013-005512-10-IE        4.9
#> 158 2013-005512-10-IE       4.10
#> 159 2013-005512-10-IE       4.11
#> 160 2013-005512-10-IE       4.12
#> 161 2013-005512-10-IE         10
#> 162 2013-005512-10-IT          4
#> 163 2013-005512-10-IT        4.1
#> 164 2013-005512-10-IT        4.2
#> 165 2013-005512-10-IT        4.3
#> 166 2013-005512-10-IT        4.4
#> 167 2013-005512-10-IT        4.5
#> 168 2013-005512-10-IT        4.6
#> 169 2013-005512-10-IT        4.7
#> 170 2013-005512-10-IT        4.8
#> 171 2013-005512-10-IT        4.9
#> 172 2013-005512-10-IT       4.10
#> 173 2013-005512-10-IT       4.11
#> 174 2013-005512-10-IT       4.12
#> 175 2013-005512-10-IT         10
#> 176 2013-005512-10-NL          4
#> 177 2013-005512-10-NL        4.1
#> 178 2013-005512-10-NL        4.2
#> 179 2013-005512-10-NL        4.3
#> 180 2013-005512-10-NL        4.4
#> 181 2013-005512-10-NL        4.5
#> 182 2013-005512-10-NL        4.6
#> 183 2013-005512-10-NL        4.7
#> 184 2013-005512-10-NL        4.8
#> 185 2013-005512-10-NL        4.9
#> 186 2013-005512-10-NL       4.10
#> 187 2013-005512-10-NL       4.11
#> 188 2013-005512-10-NL       4.12
#> 189 2013-005512-10-NL         10
#> 190 2013-005512-10-PL          4
#> 191 2013-005512-10-PL        4.1
#> 192 2013-005512-10-PL        4.2
#> 193 2013-005512-10-PL        4.3
#> 194 2013-005512-10-PL        4.4
#> 195 2013-005512-10-PL        4.5
#> 196 2013-005512-10-PL        4.6
#> 197 2013-005512-10-PL        4.7
#> 198 2013-005512-10-PL        4.8
#> 199 2013-005512-10-PL        4.9
#> 200 2013-005512-10-PL       4.10
#>                                                                                                                         name
#> 1                                                                                                    endPoints.endPoint.unit
#> 2   endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 3                                                                                                    endPoints.endPoint.unit
#> 4                                                                                                    endPoints.endPoint.unit
#> 5   endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 6   endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 7   endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 8   endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 9   endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 10                                                                                                   endPoints.endPoint.unit
#> 11  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 12                                                                                                   endPoints.endPoint.unit
#> 13  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 14                                                                                                   endPoints.endPoint.unit
#> 15                                                                                                   endPoints.endPoint.unit
#> 16  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 17  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 18  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 19  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 20  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 21                                                                                                   endPoints.endPoint.unit
#> 22  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 23                                                                                                   endPoints.endPoint.unit
#> 24  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 25                                                                                                   endPoints.endPoint.unit
#> 26                                                                                                   endPoints.endPoint.unit
#> 27  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 28  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 29  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 30  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 31  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 32                                                                                                   endPoints.endPoint.unit
#> 33  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 34                                                                                                   endPoints.endPoint.unit
#> 35  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 36                                                                                                   endPoints.endPoint.unit
#> 37                                                                                                   endPoints.endPoint.unit
#> 38  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 39  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 40  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 41  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 42  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 43                                                                                                   endPoints.endPoint.unit
#> 44  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 45                                                                                                   endPoints.endPoint.unit
#> 46  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 47                                                                                                   endPoints.endPoint.unit
#> 48                                                                                                   endPoints.endPoint.unit
#> 49  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 50  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 51  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 52  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 53  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 54                                                                                                   endPoints.endPoint.unit
#> 55  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 56                                                                                                   endPoints.endPoint.unit
#> 57  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 58                                                                                                   endPoints.endPoint.unit
#> 59                                                                                                   endPoints.endPoint.unit
#> 60  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 61  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 62  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 63  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 64  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 65                                                                                                   endPoints.endPoint.unit
#> 66  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 67                                                                                                   endPoints.endPoint.unit
#> 68  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 69                                                                                                   endPoints.endPoint.unit
#> 70                                                                                                   endPoints.endPoint.unit
#> 71  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 72  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 73  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 74  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 75  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 76                                                                                                   endPoints.endPoint.unit
#> 77  endPoints.endPoint.subjectAnalysisSetReportingGroups.subjectAnalysisSetReportingGroup.tendencyValues.tendencyValue.value
#> 78                                                                                                   endPoints.endPoint.unit
#> 79                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 80                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 81                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 82                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 83                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 84                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 85                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 86                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 87                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 88                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 89                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 90                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 91                                                                                                   endPoints.endPoint.unit
#> 92                                                                                                   endPoints.endPoint.unit
#> 93                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 94                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 95                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 96                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 97                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 98                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 99                                endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 100                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 101                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 102                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 103                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 104                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 105                                                                                                  endPoints.endPoint.unit
#> 106                                                                                                  endPoints.endPoint.unit
#> 107                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 108                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 109                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 110                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 111                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 112                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 113                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 114                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 115                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 116                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 117                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 118                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 119                                                                                                  endPoints.endPoint.unit
#> 120                                                                                                  endPoints.endPoint.unit
#> 121                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 122                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 123                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 124                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 125                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 126                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 127                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 128                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 129                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 130                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 131                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 132                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 133                                                                                                  endPoints.endPoint.unit
#> 134                                                                                                  endPoints.endPoint.unit
#> 135                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 136                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 137                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 138                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 139                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 140                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 141                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 142                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 143                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 144                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 145                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 146                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 147                                                                                                  endPoints.endPoint.unit
#> 148                                                                                                  endPoints.endPoint.unit
#> 149                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 150                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 151                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 152                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 153                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 154                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 155                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 156                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 157                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 158                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 159                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 160                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 161                                                                                                  endPoints.endPoint.unit
#> 162                                                                                                  endPoints.endPoint.unit
#> 163                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 164                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 165                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 166                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 167                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 168                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 169                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 170                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 171                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 172                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 173                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 174                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 175                                                                                                  endPoints.endPoint.unit
#> 176                                                                                                  endPoints.endPoint.unit
#> 177                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 178                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 179                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 180                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 181                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 182                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 183                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 184                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 185                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 186                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 187                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 188                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 189                                                                                                  endPoints.endPoint.unit
#> 190                                                                                                  endPoints.endPoint.unit
#> 191                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 192                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 193                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 194                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 195                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 196                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 197                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 198                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 199                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#> 200                               endPoints.endPoint.armReportingGroups.armReportingGroup.tendencyValues.tendencyValue.value
#>                            value
#> 1                           Days
#> 2                            7.0
#> 3   At least 1 response (number)
#> 4          Overall Response Rate
#> 5                           0.63
#> 6                              0
#> 7                           0.65
#> 8                           0.59
#> 9                           0.60
#> 10  Percentage of treatment time
#> 11                          78.6
#> 12                          Days
#> 13                           7.0
#> 14  At least 1 response (number)
#> 15         Overall Response Rate
#> 16                          0.63
#> 17                             0
#> 18                          0.65
#> 19                          0.59
#> 20                          0.60
#> 21  Percentage of treatment time
#> 22                          78.6
#> 23                          Days
#> 24                           7.0
#> 25  At least 1 response (number)
#> 26         Overall Response Rate
#> 27                          0.63
#> 28                             0
#> 29                          0.65
#> 30                          0.59
#> 31                          0.60
#> 32  Percentage of treatment time
#> 33                          78.6
#> 34                          Days
#> 35                           7.0
#> 36  At least 1 response (number)
#> 37         Overall Response Rate
#> 38                          0.63
#> 39                             0
#> 40                          0.65
#> 41                          0.59
#> 42                          0.60
#> 43  Percentage of treatment time
#> 44                          78.6
#> 45                          Days
#> 46                           7.0
#> 47  At least 1 response (number)
#> 48         Overall Response Rate
#> 49                          0.63
#> 50                             0
#> 51                          0.65
#> 52                          0.59
#> 53                          0.60
#> 54  Percentage of treatment time
#> 55                          78.6
#> 56                          Days
#> 57                           7.0
#> 58  At least 1 response (number)
#> 59         Overall Response Rate
#> 60                          0.63
#> 61                             0
#> 62                          0.65
#> 63                          0.59
#> 64                          0.60
#> 65  Percentage of treatment time
#> 66                          78.6
#> 67                          Days
#> 68                           7.0
#> 69  At least 1 response (number)
#> 70         Overall Response Rate
#> 71                          0.63
#> 72                             0
#> 73                          0.65
#> 74                          0.59
#> 75                          0.60
#> 76  Percentage of treatment time
#> 77                          78.6
#> 78       responses to injections
#> 79                           102
#> 80                            16
#> 81                             2
#> 82                           118
#> 83                           163
#> 84                            27
#> 85                            14
#> 86                            89
#> 87                            20
#> 88                            14
#> 89                             3
#> 90                            11
#> 91                      subjects
#> 92       responses to injections
#> 93                           102
#> 94                            16
#> 95                             2
#> 96                           118
#> 97                           163
#> 98                            27
#> 99                            14
#> 100                           89
#> 101                           20
#> 102                           14
#> 103                            3
#> 104                           11
#> 105                     subjects
#> 106      responses to injections
#> 107                          102
#> 108                           16
#> 109                            2
#> 110                          118
#> 111                          163
#> 112                           27
#> 113                           14
#> 114                           89
#> 115                           20
#> 116                           14
#> 117                            3
#> 118                           11
#> 119                     subjects
#> 120      responses to injections
#> 121                          102
#> 122                           16
#> 123                            2
#> 124                          118
#> 125                          163
#> 126                           27
#> 127                           14
#> 128                           89
#> 129                           20
#> 130                           14
#> 131                            3
#> 132                           11
#> 133                     subjects
#> 134      responses to injections
#> 135                          102
#> 136                           16
#> 137                            2
#> 138                          118
#> 139                          163
#> 140                           27
#> 141                           14
#> 142                           89
#> 143                           20
#> 144                           14
#> 145                            3
#> 146                           11
#> 147                     subjects
#> 148      responses to injections
#> 149                          102
#> 150                           16
#> 151                            2
#> 152                          118
#> 153                          163
#> 154                           27
#> 155                           14
#> 156                           89
#> 157                           20
#> 158                           14
#> 159                            3
#> 160                           11
#> 161                     subjects
#> 162      responses to injections
#> 163                          102
#> 164                           16
#> 165                            2
#> 166                          118
#> 167                          163
#> 168                           27
#> 169                           14
#> 170                           89
#> 171                           20
#> 172                           14
#> 173                            3
#> 174                           11
#> 175                     subjects
#> 176      responses to injections
#> 177                          102
#> 178                           16
#> 179                            2
#> 180                          118
#> 181                          163
#> 182                           27
#> 183                           14
#> 184                           89
#> 185                           20
#> 186                           14
#> 187                            3
#> 188                           11
#> 189                     subjects
#> 190      responses to injections
#> 191                          102
#> 192                           16
#> 193                            2
#> 194                          118
#> 195                          163
#> 196                           27
#> 197                           14
#> 198                           89
#> 199                           20
#> 200                           14
#>                                                                                                                        where
#> 1                                                                                                   Time to Overall Response
#> 2                                                                                                   Time to Overall Response
#> 3                                                                                               Durability of First Response
#> 4                                                                                                           Overall Response
#> 5                                                                                                           Overall Response
#> 6                                                                                                           Overall Response
#> 7                                                                                                           Overall Response
#> 8                                                                                                           Overall Response
#> 9                                                                                                           Overall Response
#> 10                                                                                           Cumulative Duration of Response
#> 11                                                                                           Cumulative Duration of Response
#> 12                                                                                                  Time to Overall Response
#> 13                                                                                                  Time to Overall Response
#> 14                                                                                              Durability of First Response
#> 15                                                                                                          Overall Response
#> 16                                                                                                          Overall Response
#> 17                                                                                                          Overall Response
#> 18                                                                                                          Overall Response
#> 19                                                                                                          Overall Response
#> 20                                                                                                          Overall Response
#> 21                                                                                           Cumulative Duration of Response
#> 22                                                                                           Cumulative Duration of Response
#> 23                                                                                                  Time to Overall Response
#> 24                                                                                                  Time to Overall Response
#> 25                                                                                              Durability of First Response
#> 26                                                                                                          Overall Response
#> 27                                                                                                          Overall Response
#> 28                                                                                                          Overall Response
#> 29                                                                                                          Overall Response
#> 30                                                                                                          Overall Response
#> 31                                                                                                          Overall Response
#> 32                                                                                           Cumulative Duration of Response
#> 33                                                                                           Cumulative Duration of Response
#> 34                                                                                                  Time to Overall Response
#> 35                                                                                                  Time to Overall Response
#> 36                                                                                              Durability of First Response
#> 37                                                                                                          Overall Response
#> 38                                                                                                          Overall Response
#> 39                                                                                                          Overall Response
#> 40                                                                                                          Overall Response
#> 41                                                                                                          Overall Response
#> 42                                                                                                          Overall Response
#> 43                                                                                           Cumulative Duration of Response
#> 44                                                                                           Cumulative Duration of Response
#> 45                                                                                                  Time to Overall Response
#> 46                                                                                                  Time to Overall Response
#> 47                                                                                              Durability of First Response
#> 48                                                                                                          Overall Response
#> 49                                                                                                          Overall Response
#> 50                                                                                                          Overall Response
#> 51                                                                                                          Overall Response
#> 52                                                                                                          Overall Response
#> 53                                                                                                          Overall Response
#> 54                                                                                           Cumulative Duration of Response
#> 55                                                                                           Cumulative Duration of Response
#> 56                                                                                                  Time to Overall Response
#> 57                                                                                                  Time to Overall Response
#> 58                                                                                              Durability of First Response
#> 59                                                                                                          Overall Response
#> 60                                                                                                          Overall Response
#> 61                                                                                                          Overall Response
#> 62                                                                                                          Overall Response
#> 63                                                                                                          Overall Response
#> 64                                                                                                          Overall Response
#> 65                                                                                           Cumulative Duration of Response
#> 66                                                                                           Cumulative Duration of Response
#> 67                                                                                                  Time to Overall Response
#> 68                                                                                                  Time to Overall Response
#> 69                                                                                              Durability of First Response
#> 70                                                                                                          Overall Response
#> 71                                                                                                          Overall Response
#> 72                                                                                                          Overall Response
#> 73                                                                                                          Overall Response
#> 74                                                                                                          Overall Response
#> 75                                                                                                          Overall Response
#> 76                                                                                           Cumulative Duration of Response
#> 77                                                                                           Cumulative Duration of Response
#> 78  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 79  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 80  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 81  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 82  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 83  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 84  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 85  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 86  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 87  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 88  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 89  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 90  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 91                                                      Number of Subjects with Response to Immune Tolerance Induction (ITI)
#> 92  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 93  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 94  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 95  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 96  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 97  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 98  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 99  Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 100 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 101 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 102 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 103 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 104 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 105                                                     Number of Subjects with Response to Immune Tolerance Induction (ITI)
#> 106 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 107 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 108 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 109 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 110 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 111 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 112 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 113 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 114 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 115 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 116 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 117 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 118 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 119                                                     Number of Subjects with Response to Immune Tolerance Induction (ITI)
#> 120 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 121 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 122 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 123 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 124 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 125 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 126 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 127 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 128 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 129 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 130 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 131 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 132 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 133                                                     Number of Subjects with Response to Immune Tolerance Induction (ITI)
#> 134 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 135 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 136 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 137 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 138 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 139 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 140 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 141 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 142 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 143 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 144 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 145 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 146 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 147                                                     Number of Subjects with Response to Immune Tolerance Induction (ITI)
#> 148 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 149 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 150 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 151 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 152 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 153 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 154 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 155 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 156 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 157 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 158 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 159 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 160 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 161                                                     Number of Subjects with Response to Immune Tolerance Induction (ITI)
#> 162 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 163 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 164 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 165 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 166 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 167 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 168 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 169 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 170 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 171 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 172 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 173 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 174 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 175                                                     Number of Subjects with Response to Immune Tolerance Induction (ITI)
#> 176 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 177 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 178 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 179 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 180 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 181 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 182 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 183 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 184 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 185 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 186 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 187 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 188 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 189                                                     Number of Subjects with Response to Immune Tolerance Induction (ITI)
#> 190 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 191 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 192 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 193 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 194 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 195 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 196 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 197 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 198 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 199 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#> 200 Number of rFVIIIFc Injections with Excellent or Good, Moderate or None Treatment Response Assessed Using a 4-Point Scale
#>  [ reached 'max' / getOption("max.print") -- omitted 17 rows ]